18 reports of this reaction
1.7% of all SILVER NITRATE reports
#9 most reported adverse reaction
HALLUCINATION is the #9 most commonly reported adverse reaction for SILVER NITRATE, manufactured by Boiron. There are 18 FDA adverse event reports linking SILVER NITRATE to HALLUCINATION. This represents approximately 1.7% of all 1,031 adverse event reports for this drug.
Patients taking SILVER NITRATE who experience hallucination should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HALLUCINATION is a less commonly reported adverse event for SILVER NITRATE, but still significant enough to appear in the safety profile.
In addition to hallucination, the following adverse reactions have been reported for SILVER NITRATE:
The following drugs have also been linked to hallucination in FDA adverse event reports:
HALLUCINATION has been reported as an adverse event in 18 FDA reports for SILVER NITRATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
HALLUCINATION accounts for approximately 1.7% of all adverse event reports for SILVER NITRATE, making it a notable side effect.
If you experience hallucination while taking SILVER NITRATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.